Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia

The rarity of severe complications of this disease in children makes randomized clinical trials in immune thrombocytopenia (ITP) unfeasible. Therefore, the current management recommendations for ITP are largely dependent on clinical expertise and observations. As part of its discussions during the I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamary, Hannah, Roganovic, Jelena, Chitlur, Meera, Nugent, Diane J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Management Endpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900598/
https://www.ncbi.nlm.nih.gov/pubmed/20358200
http://dx.doi.org/10.1007/s00277-010-0941-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900598/
https://www.ncbi.nlm.nih.gov/pubmed/20358200
http://dx.doi.org/10.1007/s00277-010-0941-1

Ejemplares similares